ANUHPHR

Anuh Pharma Share Price

 

 

Start SIP in ANUHPHR

Start SIP

Performance

  • Low
  • ₹79
  • High
  • ₹80
  • 52 Week Low
  • ₹74
  • 52 Week High
  • ₹123
  • Open Price₹79
  • Previous Close₹79
  • Volume10,550

Investment Returns

  • Over 1 Month -2.3%
  • Over 3 Month -8.47%
  • Over 6 Month -26.84%
  • Over 1 Year -28.29%

Smart Investing Starts Here Start SIP with Anuh Pharma for Steady Growth!

Invest Now

Anuh Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20.6
  • PEG Ratio
  • -0.6
  • Market Cap Cr
  • 796
  • P/B Ratio
  • Average True Range
  • 2.91
  • EPS
  • 3.86
  • Dividend Yield
  • 1.9
  • MACD Signal
  • -1.14
  • RSI
  • 46.22
  • MFI
  • 65.42

Anuh Pharma Financials

Anuh Pharma Technicals

EMA & SMA

Current Price
₹79.38
+ 0.56 (0.71%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹79.90
  • 50 Day
  • ₹82.15
  • 100 Day
  • ₹85.52
  • 200 Day
  • ₹89.50

Resistance and Support

79.3 Pivot Speed
  • R3 80.34
  • R2 79.97
  • R1 79.67
  • S1 79.00
  • S2 78.63
  • S3 78.33

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Anuh Pharma has an operating revenue of Rs. 730.01 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 9% is okay, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 38 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Anuh Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-07 Quarterly Results
2025-08-08 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2025-05-23 Audited Results, Dividend & Bonus issue
2025-02-07 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2024-11-08 Quarterly Results
Date Purpose Remarks
2025-08-15 FINAL Rs.1.50 per share(30%)Final Dividend (RD date revised)
View Anuh Pharma Dividend History Arrow
Date Purpose Remarks
2025-07-15 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 5/-

Anuh Pharma F&O

Anuh Pharma Shareholding Pattern

71.82%
0%
0%
0%
23.86%
4.32%

About Anuh Pharma

  • NSE Symbol
  • ANUHPHR
  • BSE Symbol
  • 506260
  • Joint Managing Director
  • Mr. Ritesh B Shah
  • ISIN
  • INE489G01022

Similar Stocks to Anuh Pharma

Anuh Pharma FAQs

Anuh Pharma share price is ₹79 As on 12 December, 2025 | 20:39

The Market Cap of Anuh Pharma is ₹795.6 Cr As on 12 December, 2025 | 20:39

The P/E ratio of Anuh Pharma is 20.6 As on 12 December, 2025 | 20:39

The PB ratio of Anuh Pharma is 2.4 As on 12 December, 2025 | 20:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23